A carregar...
真实世界中伊马替尼在BCR-ABL阳性急性淋巴细胞白血病中的应用
OBJECTIVE: To explore the efficacy and prognostic factors of imatinib (IM) combined with chemotherapy for BCR-ABL gene positive acute lymphoblastic leukemia (ALL). METHODS: A total of 209 BCR-ABL(+)ALL patients treated with imatinib plus chemotherapy from April 2003 to August 2015 were enrolled in t...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364881/ https://ncbi.nlm.nih.gov/pubmed/27801322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.10.014 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|